ArticleFrontiers in bioscience (Landmark edition)2022

Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy.

Chang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.